Sources | Names Used |
---|---|
CTRPv2 | navitoclax:birinapant (1:1 mol/mol) |
PharmacoGx | navitoclax:birinapant (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-11 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-09 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
mRNA | ZIK1 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-09 |
mRNA | CPXM1 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | CDKN2C | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
mRNA | C19orf18 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | RIPK1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |